(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Harmonic Beats Q1 Earnings Estimates, Trex Company Upgraded to Buy, MSCI Receives Overweight Rating and Price Target at Wells Fargo

May 09th, 2023

Harmonic Inc. (Nasdaq: HLIT) reported better than expected Q1 earnings, with adjusted earnings per share (EPS) of $0.12, beating the consensus estimate of $0.08. This news led to a surge in the company's stock price, which rose by 19.70% to $16.14 in. Read more

Longeveron's Lomecel-B shows promise for HLHS patients; Plug Power and Genius Sports report mixed Q1 earnings

May 09th, 2023

Longeveron Inc. (Nasdaq: LGVN) released new long-term follow-up data from its ELPIS I trial, highlighting the potential survival benefit of Lomecel-B for patients with hypoplastic left heart syndrome (HLHS). HLHS is a rare and life-threatening congen. Read more

Biotech Companies Report Q1 Results: Neuronetics Beats Consensus, Voyager Therapeutics Surpasses Expectations, Y-mAbs Therapeutics Outperforms Estimates

May 09th, 2023

Neuronetics, Inc. (Nasdaq: STIM) has reported a Q1 loss of $0.38 per share, which was slightly better than the consensus loss of $0.39 per share. As of this writing, $STIM is trading at $2.89, up by 31.36% or $0.69. Meanwhile, Voyager Therapeutics. Read more

Novavax Reports Better-than-Expected Q1 Loss, Implements Cost-Cutting Measures to Extend Cash Runway and Improve Efficiency

May 09th, 2023

Novavax, Inc. (Nasdaq: NVAX) reported a Q1 loss of $3.41 per share, slightly better than the consensus loss of $3.46 per share.  In response to the challenging times, the company has announced cost-cutting measures to extend its cash runway a. Read more

Ensysce Biosciences Announces Successful Completion of Clinical Study for Pain Medication with Overdose Protection, Amgen and TScan Therapeutics Collaborate to Identify Antigens for Crohn's Disease Treatment

May 09th, 2023

Ensysce Biosciences, Inc. (Nasdaq: ENSC) has completed the clinical study of its first pain medication with overdose protection, PF614-MPAR, known as PF614-MPAR-101. The final Part B of the study showed that PF614-MPAR effectively reduced opioid deli. Read more

ClearOne Declares Special Dividend, Shares Surge in Pre-market Trading

May 09th, 2023

ClearOne (NASDAQ: CLRO) has announced a special one-time cash dividend of $1.00 per share of ClearOne common stock, payable on May 31, 2023, to shareholders of record on May 22, 2023.  Eric L. Robinson, the Chairman of the Board of Directors . Read more

Barclays Raises McKesson Price Target, Vertex Energy Misses Q1 Estimates, Atkore Beats Q2 Expectations

May 09th, 2023

McKesson Corporation (NYSE: MCK) has had its price target raised by Barclays from $415 to $420. The stock is responding positively in pre-market trading, currently up 4.44% to $384.94. However, Vertex Energy, Inc. (Nasdaq: VTNR) has reported Q1 ea. Read more

Market Update: AudioCodes Falls Short on Q1 Earnings, Howmet Aerospace Receives Price Target Boost, NeoGenomics Upgraded to Buy

May 09th, 2023

AudioCodes Ltd. (Nasdaq: AUDC) has reported Q1 earnings per share of $0.08, falling short of the consensus estimate of $0.17. Despite this, the stock is trading higher in pre-market, currently up 6.21% to $10.61. Barclays has raised the price targ. Read more

Shoals Technologies and Palantir beat expectations in Q1 earnings, while Avantax falls short

May 08th, 2023

Shoals Technologies Group, Inc. (Nasdaq: SHLS) reported better-than-expected Q1 earnings with an EPS of $0.14, beating the consensus estimate of $0.10. In after-hours trading, SHLS is up $2.28 (+11.56%) and is currently trading at $22.00. Palantir. Read more

Shockwave Medical and CRISPR Therapeutics Beat Expectations in Q1 Earnings, Ocular Therapeutix Falls Short

May 08th, 2023

Shockwave Medical, Inc. (Nasdaq: SWAV) reported better-than-expected Q1 earnings, with an EPS of $1.03 versus the consensus estimate of $0.81. In after-hours trading, SWAV is up $10.04 (+3.65%) and is currently trading at $285.00. On the other han. Read more